| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | -2.8% |
| R&D Expense | $126.2M | +0.2% |
| SG&A Expense | $31.7M | +16.7% |
| Operating Income | -$131.4M | -4.4% |
| Interest Expense | $598K | — |
| Pre-tax Income | -$127.4M | -1.5% |
| Income Tax | $0 | — |
| Net Income | -$127.4M | -1.5% |
| EPS (Basic) | -$2.60 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.7M | +1.7% |
| Short-term Investments | $111.6M | -45.1% |
| Current Assets | $243.1M | -28.7% |
| Total Assets | $247.9M | -28.7% |
| Current Liabilities | $31.2M | -29.2% |
| Total Liabilities | $32.3M | -32.2% |
| Stockholders' Equity | $215.6M | -28.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.1M | -0.3% |
| Capital Expenditures | $795K | -27.8% |
| Investing Cash Flow | $91.5M | +676.7% |
| Financing Cash Flow | $18.8M | -85.5% |
| Free Cash Flow | -$108.9M | +0.0% |
| +4.1% |
| EPS (Diluted) | -$2.60 | +4.1% |